Optimal dose of etanercept in the treatment of rheumatoid arthritis

Etanercept (ETN) is one of a number of biological therapies targeting the proinflammatory cytokine tumor necrosis factor-alpha that have demonstrated efficacy in the management of rheumatoid arthritis (RA). As experience has grown, a number of different treatment strategies have been investigated to...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Elizabeth Mary, Marks, Jonathan Lewis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045112/
https://www.ncbi.nlm.nih.gov/pubmed/27790032
http://dx.doi.org/10.2147/OARRR.S41409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045112/
https://www.ncbi.nlm.nih.gov/pubmed/27790032
http://dx.doi.org/10.2147/OARRR.S41409

Ejemplares similares